Skip to main content
Uni-Bio Science Group Limited logo

Uni-Bio Science Group Limited — Investor Relations & Filings

Ticker · 690 HKEX Manufacturing
Open in API
Filings indexed 1,065 across all filing types
Latest filing 2023-04-20 AGM Information
Country HK Hong Kong
Listing HKEX 690

About Uni-Bio Science Group Limited

http://www.uni-bioscience.com

Uni-Bio Science Group Limited is an innovative biopharmaceutical enterprise specializing in the R&D, manufacturing, and sales of biological and chemical pharmaceutical products. The company's core strategy centers on regenerative medicine, focusing on therapeutic areas such as endocrinology, dermatology, and ophthalmology. Key research pipelines address bone and muscle regeneration (including osteoporosis), skin and tissue repair (burns, chronic wounds, and medical aesthetics), and ocular regeneration (corneal damage and macular degeneration). Unique technological platforms include the ECO-KSFA® micro-protein manufacturing system for high-stability biologics and smart hydrogel technology for advanced tissue engineering and targeted delivery solutions.

Recent filings

Filing Released Lang Actions
GRANT OF GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES, RE-ELECTION OF DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING
AGM Information Classification · 100% confidence The document is a circular from Uni-Bio Science Group Limited dated 26 April 2023, containing detailed information about the upcoming Annual General Meeting (AGM) scheduled for 19 May 2023. It includes the notice of the AGM, resolutions to be proposed such as the grant of general mandates to issue and repurchase shares, re-election of directors, and adoption of new memorandum and articles of association. The document also contains explanatory statements and biographical details of directors proposed for re-election. The content is typical of materials sent to shareholders in advance of an AGM to inform them and solicit their votes. The presence of a notice of AGM and proxy form instructions further confirms this. The document is not a report of voting results, not a financial report, nor a regulatory filing or announcement of report publication. It is a circular containing AGM information and materials related to the meeting itself.
2023-04-20 English
Annual Report 2022
Annual Report Classification · 100% confidence The document contains detailed sections typical of a comprehensive annual report, including a Chairman's Statement, Management Discussion and Analysis, Corporate Governance Report, Directors' Report, Independent Auditor's Report, consolidated financial statements, notes to the financial statements, and a five-year financial summary. It covers the full fiscal year ended 31 December 2022, with extensive financial data and analysis. The length of the document (15,000 characters) and the depth of content confirm it is the full Annual Report rather than an announcement or summary. Therefore, the document is classified as an Annual Report (10-K). FY 2022
2023-04-20 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2023
Regulatory Filings Classification · 95% confidence The document is a detailed monthly report on movements in securities for Uni-Bio Science Group Limited, including authorized share capital, issued shares, share options, and confirmations related to securities issued. It is addressed to the Hong Kong Exchanges and Clearing Limited and references compliance with the Exchange Listing Rules. The document does not contain financial statements or earnings data but focuses on share capital and share movements. It is not an announcement of a report but a substantive regulatory filing about share capital and securities movements. This fits the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2023-04-03 English
ANNOUNCEMENT OF FINAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2022
Annual Report Classification · 95% confidence The document is an announcement titled 'ANNOUNCEMENT OF FINAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2022' from Uni-Bio Science Group Limited. It contains detailed financial data for the full fiscal year 2022, including revenue, profit, segment financials, and management discussion and analysis. The presence of audited consolidated results, comprehensive financial figures, and extensive management commentary indicates this is a full annual financial report. The document is about 15,000 characters long, which is consistent with a full report rather than a brief announcement or summary. There is no indication that this is merely a notice of report publication or a certification. Therefore, this document fits the definition of an Annual Report (10-K equivalent). FY 2022
2023-03-27 English
DATE OF BOARD MEETING
Regulatory Filings Classification · 95% confidence The document is an announcement from Uni-Bio Science Group Limited regarding the date of a board meeting scheduled to approve the financial results for the year ended 31 December 2022 and to consider the payment of a final dividend. The document is short (1649 characters) and serves as a notice of an upcoming event rather than containing any financial data or results itself. It does not contain the actual financial report or detailed financial information. Therefore, it is an announcement related to the timing and agenda of a board meeting, not the report itself. According to the classification rules, such announcements are best classified as Regulatory Filings (RNS) because they do not fit into other specific categories and are not the report itself.
2023-03-15 English
POSITIVE PROFIT ALERT
Capital/Financing Update Classification · 95% confidence The document is titled 'POSITIVE PROFIT ALERT' and is an announcement by the Board of Uni-Bio Science Group Limited regarding a preliminary assessment of the unaudited consolidated management accounts for the year ended 31 December 2022. It states an expected profit increase and provides some reasons for this, but it explicitly mentions that the annual results are still being prepared and will be announced later. The document is short (3985 characters) and serves as an early profit alert rather than a full financial report. It does not contain full financial statements or detailed analysis typical of an Annual Report (10-K) or Interim Report (IR). It is also not a full Earnings Release (ER) but rather a profit alert, which is a type of capital/financial update. Given the nature of the announcement and the reference to Listing Rules and Inside Information Provisions, this fits best under Capital/Financing Update (CAP) as it updates investors on expected financial performance before the official results are published.
2023-03-06 English

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.